SCHEMBL14282933

SCHEMBL14282933

O=C(CN1CCC(=C(c2ccccc2)c2ccccc2)CC1)OC1CCOC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
HTR2B P41595 1/20 0.43
OPRD1 P41143 6/20 0.43
OPRM1 P35372 5/20 0.43
OPRK1 P41145 5/20 0.43
HTR7 P34969 1/20 0.39
SETD7 Q8WTS6 1/20 0.39
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39
P2RX7 Q99572 1/20 0.38
ADAM10 O14672 4/20 0.37
MMP2 P08253 4/20 0.37
MMP1 P03956 3/20 0.37
MMP3 P08254 3/20 0.37
MMP9 P14780 3/20 0.37
CTSL P07711 1/20 0.37
FNTA P49354 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14282934 0.93 DRD2 (0.47) DRD2DRD4HTR2AHTR2CHTR2B
SCHEMBL14282935 0.89 ALDH1A1 (0.43) DRD2DRD4HTR2AHTR2CHTR2B
SCHEMBL14282936 0.82 ALDH1A1 (0.48) DRD2DRD4HTR2AHTR2CHTR2B
SCHEMBL14282954 0.76 BCHE (0.48) DRD2DRD4HTR2AHTR2CHTR2B
SCHEMBL14559349 0.76 BCHE (0.48) DRD2DRD4HTR2AHTR2CHTR2B
SCHEMBL4697602 0.73 ALDH1A1 (0.46) DRD2DRD4HTR2AHTR2CHTR2B
SCHEMBL14282904 0.73 OPRD1 (0.50) OPRD1OPRM1OPRK1HTR7SETD7
SCHEMBL4257154 0.73 SETD7 (0.56) DRD2DRD4HTR2AHTR2CHTR2B
SCHEMBL21886707 0.72 CHRNA7 (0.54) CTSLMEN1POLBKMT2A
SCHEMBL22101385 0.72 CHRNA7 (0.54) CTSLMEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7317026-B2 Sleep disorders; side effect reduction ; antihistamine antagonist HYPNION, INC. (US) 2008-01-08 US disclosed
US-7317026-B2 Sleep disorders; side effect reduction ; antihistamine antagonist HYPNION, INC. (US) 2008-01-08 US disclosed
US-7189757-B2 Treatment of sleep disorders using CNS target modulators HYPNION, INC. (US) 2007-03-13 US disclosed
US-7189757-B2 Treatment of sleep disorders using CNS target modulators HYPNION, INC. (US) 2007-03-13 US disclosed